These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26837160)

  • 1. [Multidrug-resistant bacteria require new treatment options].
    Panknin HT
    Med Monatsschr Pharm; 2015 Dec; 38(12):517-21. PubMed ID: 26837160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Old and new antibiotics for therapy of multidrug resistant bacteria].
    Pintado V
    Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():39-42. PubMed ID: 27608312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel multidrug resistant microorganisms in critically ill: a potential threat.
    Grossi PA; Tebini A; Dalla Gasperina D
    Minerva Anestesiol; 2015 Jan; 81(1):52-64. PubMed ID: 24594917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Do we really need new antibiotics?].
    Putensen C
    Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S83-4. PubMed ID: 25429536
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in antibacterial therapy against emerging bacterial pathogens.
    Pournaras S; Iosifidis E; Roilides E
    Semin Hematol; 2009 Jul; 46(3):198-211. PubMed ID: 19549574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current strategies against multi-drug resistant organisms].
    Pletz MW; Eckmann C; Hagel S; Heppner HJ; Huber K; Kämmerer W; Schmitz FJ; Wilke M; Grabein B
    Dtsch Med Wochenschr; 2015 Jun; 140(13):975-81. PubMed ID: 26115132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.
    Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V
    Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fosfomycin--its significance for treatment of diseases due to multidrug-resistant bacteria].
    Stock I
    Med Monatsschr Pharm; 2015 Jan; 38(1):4-11. PubMed ID: 26349119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multidrug-resistant bacteria in Germany. The impact of sources outside healthcare facilities].
    Idelevich EA; Lanckohr C; Horn D; Wieler LH; Becker K; Köck R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Jan; 59(1):113-23. PubMed ID: 26446586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria.
    Ruhnke M; Arnold R; Gastmeier P
    Lancet Oncol; 2014 Dec; 15(13):e606-e619. PubMed ID: 25456379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New antibiotic strategies in patients with cirrhosis and bacterial infection.
    Fernández J; Acevedo J
    Expert Rev Gastroenterol Hepatol; 2015; 9(12):1495-500. PubMed ID: 26465070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial infections in hematopoietic stem cell transplantation recipients.
    Mikulska M; Del Bono V; Viscoli C
    Curr Opin Hematol; 2014 Nov; 21(6):451-8. PubMed ID: 25295742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Emergence pathogens infections in ENT Department of Children's hospital in 2005-2008].
    Zielnik-Jurkiewicz B; Rakowska-Szkudlarek M
    Otolaryngol Pol; 2009; 63(6):513-9. PubMed ID: 20198987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
    Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention.
    Tzialla C; Borghesi A; Pozzi M; Stronati M
    Clin Chim Acta; 2015 Dec; 451(Pt A):71-7. PubMed ID: 25749408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance and management of multidrug-resistant microorganisms.
    Orsi GB; Falcone M; Venditti M
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):653-79. PubMed ID: 21819331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
    Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for multidrug-resistant bacteria.
    Giamarellou H
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):601-18. PubMed ID: 17009940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health.
    Catry B; Cavaleri M; Baptiste K; Grave K; Grein K; Holm A; Jukes H; Liebana E; Lopez Navas A; Mackay D; Magiorakos AP; Moreno Romo MA; Moulin G; Muñoz Madero C; Matias Ferreira Pomba MC; Powell M; Pyörälä S; Rantala M; Ružauskas M; Sanders P; Teale C; Threlfall EJ; Törneke K; van Duijkeren E; Torren Edo J
    Int J Antimicrob Agents; 2015 Sep; 46(3):297-306. PubMed ID: 26215780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Old' antibiotics for emerging multidrug-resistant bacteria.
    Bergen PJ; Landersdorfer CB; Lee HJ; Li J; Nation RL
    Curr Opin Infect Dis; 2012 Dec; 25(6):626-33. PubMed ID: 23041772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.